"Lipid Formulations For Nucleic Acid Delivery" in Patent Application Approval Process (USPTO 20230372245).

The patent application by Arbutus Biopharma Corporation discusses the development of lipid particles that can safely and effectively deliver nucleic acids for therapeutic purposes. These lipid particles have shown promise in targeting specific tissues and mediating gene expression at tumor sites. The invention aims to provide new methods and compositions for treating diseases such as cancer and atherosclerosis by introducing nucleic acids into cells and downregulating gene expression. The patent application covers specific formulations of these lipid particles, methods of making and administering them, and their potential applications in drug delivery and gene therapy. [Extracted from the article]